- About Us
-
Services
- Small Molecule Discovery
- Small Molecule CDMO
- Biologics
-
Infrastructure
- By Services
- By Locations
- Virtual Tour
- Digital Edge Suite
-
Resources
- Content Library
- Events
- News
-
Deep Dive
- Small Molecule Discovery
-
Small Molecule CDMO
- CMC & Pharma Regulatory Support
- Clinical Supplies and Pharma Commercial Manufacturing Services
- Drug Product Characterization Studies and Testing Services
- Drug product formulation development
- Flow Chemistry
- Formulation Development for Injectables
- Integrating Drug Substance and Drug Product
- Preformulation Studies
- Solid oral dosage form
- Topical Dosage Forms
- Oral Liquids
- Biologics
- Contact Us
- Search
- Speak to Our Experts
Loading...
Sustainability
Our core value of sustainability drives our resolve to address societal needs and guides our ambitious ESG goals for the next decade.
Our current ESG goals
- Being committed to environmental stewardship
- Making our products accessible and affordable to patients
- Contributing to a fairer and more socially inclusive world
- Enhancing trust with our stakeholders
Reducing carbon emissions
- 100% renewable power by 2030
- Carbon neutrality in our direct operations (Scope 1 and Scope 2 emissions) by 2030
- 12.5% reduction in indirect carbon emissions across our supply chain (Scope 3 emissions) by 2030
Water Positivity
- Be water positive by 2025
Affordable and Accessible Products
- Innovative pricing models to increase accessibility
- Affordable medicines for developing countries
- Partnership with healthcare providers
Social Inclusivity Goals
- Diversity and inclusion initiatives
- Supporting underserved communities
- Creating jobs and opportunities
Building Stakeholder Trust
- Transparency in operations
- Engaging with local communities
- Ethical governance practices
Accreditations and awards
Gold Medal status by EcoVadis
We have been awarded ‘Gold Medal’ status by EcoVadis, the global sustainability ratings agency, for its score of 72 out of 100 in its scorecard for 2023.
Dow Jones Sustainability Index
We have become the first Indian pharma company to earn a place in the Standard & Poor Dow Jones Sustainability World Index (DJSI World) for 2023. Alongside our debut in DJSI World, we also retain our place in the Dow Jones Sustainability Index for Emerging Markets (DJSI EM) for the 8th year in a row.
Asia-Pacific Climate Leader 2024 by the Financial Times (London)
For the second year in a row, The Financial Times (London) has named us an ‘Asia-Pacific Climate Leader' in its 2024 list. The annual study is compiled by Financial Times and Statista. Asia-Pacific Climate Leaders 2024 is a list of 350 Asia-Pacific companies that have achieved the greatest reduction in their core emissions intensity over the 5-year period between 2017 and 2022.
Gold Medal status by EcoVadis
We have been awarded ‘Gold Medal’ status by EcoVadis, the global sustainability ratings agency, for its score of 72 out of 100 in its scorecard for 2023.
Dow Jones Sustainability Index
We have become the first Indian pharma company to earn a place in the Standard & Poor Dow Jones Sustainability World Index (DJSI World) for 2023. Alongside our debut in DJSI World, we also retain our place in the Dow Jones Sustainability Index for Emerging Markets (DJSI EM) for the 8th year in a row.
Asia-Pacific Climate Leader 2024 by the Financial Times (London)
For the second year in a row, The Financial Times (London) has named us an ‘Asia-Pacific Climate Leader' in its 2024 list. The annual study is compiled by Financial Times and Statista. Asia-Pacific Climate Leaders 2024 is a list of 350 Asia-Pacific companies that have achieved the greatest reduction in their core emissions intensity over the 5-year period between 2017 and 2022.
Our commitment towards building sustainable operations
Aurigene Pharmaceutical services has a long-standing commitment to safety and sustainability. We have been early pioneers in adopting the sustainability in our operations and have consistently set ourselves ambitious targets in favor of renewable energy, water positivity, waste management and biodiversity.
FY23 Annual Return FY24 Annual Return FY25 Annual Return CSR policy CSR Committee CSR Annual Action Plan FY26 ISO certificate for Environmental Management System Biomedical Waste Report Quality Policy ISO certificate for Occupational Health and Safety Management System
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.
Leaving already?
Don't forget to join us at
CPHI Worldwide 2023.
October 24th-26th, 2023 | Barcelona, Spain
Get ready to accelerate your drug’s journey to the market